Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. - Wikidata - awgldk - TriplyDB

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

http://www.wikidata.org/entity/Q35043719

about

Standards of medical care in diabetes--2012 Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits Diabetes mellitus and hypothyroidism: Strange bedfellows or mutual companions?Insights into type 1 diabetes from the autoimmune polyendocrine syndromes Type 1 diabetes through the life span: a position statement of the American Diabetes Association Standards of medical care in diabetes--2013 Genetics of Autoimmune Thyroiditis in Type 1 Diabetes Reveals a Novel Association With DPB1*0201: Data From the Type 1 Diabetes Genetics Consortium.Coherent somatic mutation in autoimmune disease.Celiac disease and autoimmune-associated conditions.Extrapancreatic autoantibody profiles in type I diabetes Coombs negative autoimmune hemolytic anemia in Crohn's disease.Type 1 diabetes and polyglandular autoimmune syndrome: A review Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patients.Higher Risk of Thyroid Disorders in Young Patients with Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study.IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis.Compromised central tolerance of ICA69 induces multiple organ autoimmunity.Association of type 1 diabetes mellitus and autoimmune disorders in Brazilian children and adolescents.Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.Decreased CD127 expression on CD4+ T-cells and elevated frequencies of CD4+CD25+CD127- T-cells in children with long-lasting type 1 diabetes.2013 ETA Guideline: Management of Subclinical Hypothyroidism.Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus.Systematic review: worldwide variation in the frequency of coeliac disease and changes over time.Celiac disease prevalence in a large series of patients with Behcet's disease.Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.Type 1 Diabetes and Thyroid Autoimmunity in Children.HLA-DQ genotypes - but not immune markers - differ by ethnicity in patients with childhood onset type 1 diabetes residing in Belgium.Diabetogenic Potential of Ancestral and Modern Wheat Landraces.HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma.Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members.Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity; the findings of a UK population-based family study.Electrochemiluminescence Assays for Human Islet Autoantibodies.Familial aggregation and heritability of type 1 diabetes mellitus and coaggregation of chronic diseases in affected families The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort

P2860

Q24632533-FD1B006A-4756-46E5-B838-A39926B8B875 Q26765262-55F336B8-6E81-4980-A5B1-DB90F2DE099D Q26824202-D0B3E6EC-DFB0-4AD4-864D-1FE4652F6E9C Q27006792-A169D897-B005-45AC-A987-25BD58AC840D Q28242092-E546E828-A4D7-4FE9-9915-46E693F06CA0 Q29620309-7B2E7AD7-722F-4F80-9F26-5B6E0D0FFE4E Q30997114-1813D351-1F0C-4B25-88CA-456DF9458E87 Q33837769-94BDA1F4-8709-4FB7-8C72-BC582DBDFBAC Q34367160-7017B551-9641-4094-858F-74D21CBB3DAA Q34428374-8C94F0F1-06EC-4352-92A9-EF03571A302E Q34690252-83652AEF-AD2C-41C0-BBF0-6491B21F0812 Q35049889-B5B7D81E-3334-4C95-BFD8-F31570507B4C Q35532322-DFB3F8C0-CB4B-4F3B-8393-1E4347AA9A34 Q35967496-383482EC-00C2-425C-8A03-81B0CF620176 Q36249568-B6F8E43C-676A-49A3-AF98-EFAA8AAC1A51 Q36440605-AA4193B7-9A7E-4FE3-9208-020FD607146B Q36867469-1D003915-D50B-425C-9071-B3865EE5AA70 Q37155949-59986FBB-BA8B-42CF-BCDF-FE3DD7100026 Q37375647-13331E0E-D6E4-42EA-813A-2F0E8BD4C38E Q37582449-0873DDC0-B8FA-4F46-8E28-5A3C72EA60C9 Q37643691-375E631C-948B-45C8-8420-D19E873BFCDD Q38115618-5E1C4463-82EB-429E-8C5D-900570BD3D34 Q38843131-A20BB3DD-1B65-4B0C-A536-122735E9EC26 Q40998700-F62CE138-EDC2-47C1-95A1-420E0199CD28 Q41248165-B4A1CB91-6B87-4592-AF20-DEB6ADA59B28 Q41621457-B50B33D2-1A3D-4009-8C2F-105DBA22C785 Q42352647-FA7A8316-FAF5-4A0C-AA41-352CB6560AA7 Q44002816-4A4FB5CC-90C5-42D7-9EDC-F4F8FDBE18B8 Q47569563-17B80C7D-5CB2-41BD-AE67-ACB67EC8B02C Q47686593-E7772804-CB98-4A13-B3A0-DEA8D9CE3E10 Q49325874-ACA4FE74-A005-4FEA-B345-743500EB8ED6 Q50065306-6AC21B51-6C52-4AB5-A819-33E98E76BE39 Q52599034-26E69E98-1B63-44EC-B740-13B2ABD712E2 Q57816139-490677F5-54DF-4456-A479-42578CD206C4 Q58121772-4A1E8EEA-943E-4E2D-9DEF-55F04F4C44FE

P2860

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

http://www.wikidata.org/entity/Q35043719

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

@en

type

label

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

@en

prefLabel

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

@en

P1433

Q35043719-8E53772E-722E-4A94-8FDD-C1501565F669

P1476

Q35043719-564E41A4-C022-4337-97EC-5BF797019A16

P2093

Q35043719-0133D512-30DD-490E-80D0-EC014E936A8C

Q35043719-39E3F9E3-8351-441C-8A61-DFB95468A730

Q35043719-412DC7DD-2607-4D32-8760-F3769D4E3881

Q35043719-5E683205-749E-4F88-82E9-3B1A4E7D8407

Q35043719-6F85E8C0-CA27-4F42-8DB4-E08453FEBA1C

Q35043719-76728E77-6787-4066-B8A2-B0368A62DEB7

Q35043719-98B74E1D-5FCB-4506-A712-29FB559E4064

Q35043719-E770F880-6AFF-4508-9094-BE251650C88C

P2860

Q35043719-12864095-9D0E-48A0-9B6A-5BC82C7C1ED3

Q35043719-43B52609-64C4-43C7-9743-6BF4EB8AD702

Q35043719-72458457-967E-41DD-9A3A-E19B340463ED

Q35043719-7733B60A-98BB-4BAA-BBF7-4B4C0FD28FFE

Q35043719-78E31A28-B30A-4AAD-8E3F-70D9930ADFE0

Q35043719-CE34B034-DF10-4C3D-96F5-C22DA7692007

Q35043719-D1C7A10A-2767-48D8-952D-8C9E49886830

P304

Q35043719-5B0CF6DB-B374-4D7B-A669-194E479B4352

P31

Q35043719-16963064-990B-47CB-A215-D8E020BAA20F

P356

Q35043719-531FFD7D-C3D1-44B1-A880-844B40970E3A

P407

Q35043719-82E5F493-1760-4F94-939B-8FE7D3DFB7AD

P433

Q35043719-06D7DD9C-F7E9-48B0-8134-8ACA389BD723

P478

Q35043719-C5EB2664-24D4-4178-92B6-558B5B6588B1

P577

Q35043719-FDBEB6E0-BBC3-415A-9AE6-626AC73A6D1B

P5875

Q35043719-4431F5C9-C2C9-49D3-9741-6E1E2DB581D1

P698

Q35043719-DD87C5CD-EC95-4F20-A0D8-E09EBC697783

P921

Q35043719-F13C9A92-9BF7-43E5-AE7F-8153F44DCABC

P932

Q35043719-92CA032B-45E3-444C-8151-2E1B9E8DB8C2

P356

P1433

P1476

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

@en

P2093

George S Eisenbarth

http://www.w3.org/2001/XMLSchema#string

Georgeanna J Klingensmith

http://www.w3.org/2001/XMLSchema#string

Jennifer M Barker

http://www.w3.org/2001/XMLSchema#string

Kim McFann

http://www.w3.org/2001/XMLSchema#string

Liping Yu

http://www.w3.org/2001/XMLSchema#string

Marian J Rewers

http://www.w3.org/2001/XMLSchema#string

Taylor K Armstrong

http://www.w3.org/2001/XMLSchema#string

Taylor M Triolo

http://www.w3.org/2001/XMLSchema#string

P2860

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

Screening for celiac disease in children with type 1 diabetes: two views of the controversy.

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.

Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening.

Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.

P304

1211-1213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-1756

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50831471

http://www.w3.org/2001/XMLSchema#string

P698

21430083

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3114477

http://www.w3.org/2001/XMLSchema#string